HMGB1 as a key mediator in liver disease pathogenesis
Liver diseases, both acute and chronic, continue to pose significant clinical challenges due to high morbidity and mortality rates.
Liver diseases, both acute and chronic, continue to pose significant clinical challenges due to high morbidity and mortality rates.